Skip to main navigation Skip to search Skip to main content

Nitazoxanide for treatment of intestinal parasites in children

  • Baylor College of Medicine

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Abstract

Nitazoxanide is an important new antiparasitic drug. It is effective for cryptosporidiosis in normal hosts, malnourished children and HIV patients with higher CD4 cell counts. Nitazoxanide is equivalent to metronidazole in giardiasis but may be better tolerated. It has wide spectrum activity against intestinal protozoan and helminth infections. Intestinal protozoa are important but underdiagnosed causes of persistent diarrhea in both developing and developed countries. Empiric therapy with nitazoxanide, which is effective, well-tolerated and modestly priced, may be a reasonable and more cost-effective alternative to pursuing specific diagnoses in selected populations.

Original languageEnglish
Pages (from-to)641-642
Number of pages2
JournalPediatric Infectious Disease Journal
Volume24
Issue number7
DOIs
StatePublished - Jul 2005

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 2 - Zero Hunger
    SDG 2 Zero Hunger
  2. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Diarrhea
  • Nitazoxanide
  • Parasites

Cite this